Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

NICE endorses golimumab second line for rheumatoid arthritis

By News team

The National Institute for Health and Clinical Excellence has endorsed golimumab as a second-line option for treating rheumatoid arthritis.

New guidance published today (22 June 2011) recommends golimumab (Simponi: Schering-Plough) in combination with methotrexate in adults whose rheumatoid arthritis has responded inadequately to conventional disease-modifying antirheumatic drugs (DMARDs), including methotrexate.

NICE advises that use of golimumab should follow guidance for other tumour necrosis factor (TNF) inhibitor treatments — adalimumab, etanercept and infliximab — covered by NICE technology appraisal 130.

Another condition set by NICE is that the manufacturer provides the 100mg dose of golimumab at the same cost as the 50mg dose.

For adults whose rheumatoid arthritis has responded inadequately to other DMARDs, including a TNF inhibitor, and who cannot take rituximab, golimumab in combination with methotrexate is also recommended as a treatment option, subject to certain provisos.  

NICE, however, is not recommending golimumab for methotrexate-naive rheumatoid arthritis, due to a lack of evidence.

Citation: The Pharmaceutical Journal URI: 11079292

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • Complementary and Alternative Medicine

    Complementary and Alternative Medicine

    A practical reference source on alternative and complementary therapies. Enables healthcare professionals to give knowledge-based advice.

    £43.00Buy now
  • MCQs in Pharmacy Practice

    MCQs in Pharmacy Practice

    A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.

    £25.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Rheumatic hands (808isgreat|

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.